Chemotherapy for bladder cancer with neocarzinostatin: evaluation of systemic administration.
D000328:Adult; D000368:Aged; D000855:Anorexia / Q000139:chemically induced; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy / Q000473:pathology; D005221:Fatigue / Q000139:chemically induced; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009353:Zinostatin / Q000009:adverse effects / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D009353:Zinostatin